Security Entity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

zircon missiles. they conducted drills earlier in the atlantic. but cuba's foreign ministry says none of those ships are carrying nuclear arms, and that russia's five day visit does not pose a threat to region. this all comes as cuba's foreign minister bruno rodriguez and his russian counterpart sergei lavrov, met in moscow. earlier i spoke with our cuba and america correspondent for more. you have heard there that they are at pains to stress that there is no threat to the region by these naval exercises. that this is simply — and they have been underlining this — a friendship be...

they got closer to cuba. on wednesday russia's defence ministry said two of the vessels are carriers of advanced weapons, including hypersonic zircon missiles. they conducted drills earlier in the atlantic. but cuba's foreign ministry says none of those ships are carrying nuclear arms, and that russia's five day visit does not pose a threat to region. this all comes as cuba's foreign minister bruno rodriguez and his russian counterpart sergei lavrov, met in moscow. live now to the bbc�*s central american and cuba correspondent will grant. good to see you. what are cuban officials a...

of the alleged proposed changes were workable, but some went beyond what the group had previously agreed to in talks for a ceasefire. speaking in qatar wednesday, secretary blinken reiterated that hamas was the party holding back an agreement. a deal was on the table that was virtually identical to the proposal that hamas put forward on may 6th. a deal that the entire world was behind, a deal israel has accepted, and hamas could have answered with a single word, "yesi._ instead, hamas waited nearly two weeks, and then proposed more changes, a number of which go beyond positions it ha...

The ROUTERS Act is a meaningful step toward quantifying the risks posed by vulnerabilities within these technologies.

The BIOSECURE Act (H.R. 7085), which has the potential to severely restrict the ability of U.S. biopharmaceutical companies to collaborate with certain Chinese entities without losing the ability to contract with the U.S. government, has made headlines in recent weeks.